Recon: FDA approves Regeneron's blood cancer drug; House passes Trump spending bill

• Summit Is in Talks for $15 Billion Partnership With AstraZeneca (Bloomberg)
• House Republicans pass Trump's megabill, sending the package to his desk to be signed (NPR)
• Tariffs can’t defeat the fentanyl problem in the US (STAT)
• Memo said to describe biotech industry meeting calls RFK Jr. a ‘direct threat to public health’ (STAT)
• RFK Jr. Is Playing With Babies’ Lives (Bloomberg)
• US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots (Reuters)
• The OTC Fee Fallout: Are Hundreds of Companies Ignoring FDA’s User Fee Requirements? (FDA Law Blog)

• Britain launches 10-year plan to save health service in crisis (Reuters)
• Carlyle to sell up to 10% stake in Piramal Pharma, Moneycontrol reports (Reuters)
• China approves 4 new drugs, including global 1st-in-class (Fierce Pharma)
• Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant (Fierce Pharma)
• Intuitive Surgical’s da Vinci 5 robot wins CE mark (MedTech Dive)
• Novel Pathway For Combined Drug/IVD Trials Wins Backing Of EU Nations (MedTech Insight)
• EU Life Sciences Strategy Must Address ‘Regulatory Lasagna’ (MedTech Insight)
• Questions Over UK Prevention Agenda Within NHS 10-Year Plan (MedTech Insight)

• US FDA approves Regeneron's blood cancer therapy (Reuters)
• The year is half over. Here’s where the biotech industry stands (STAT)
• Number of megarounds drop 38% in first half as biotechs struggle against worsening slump (Endpoints)
• Novartis' Cosentyx fails Phase 3 study for autoimmune disease (Endpoints)
• Structure in partnering talks for GLP-1 pill as mid-stage readout nears (Endpoints)
• Sperm Freezing Is a New Hot Market for Startups (Bloomberg)
• Boehringer backs education drive to improve bronchiectasis management (Fierce Pharma)
• Sage’s Search for Lifeline Ran Into Defiant Biogen CEO (BioSpace)

• The Trump administration is promoting wearable health devices — with or without evidence (Endpoints)
• Judge approves 23andMe sale to nonprofit led by Anne Wojcicki (MedTech Dive)
• Field Medical raises another $35M for PFA system (MedTech Dive)
• Deaths And Serious Injuries Linked To A Pair Of Heart Device Recalls (MedTech Insight)

• Hershey joins food makers in commitment to remove artitficial dyes (Food Dive)
• Foodborne Illness Costs Australia $3 Billion Each Year, Up $200 Million From 2023 (Food Safety)

• US FTC workshop criticizing medical care for transgender youth draws staff opposition (Reuters)
• Supreme Court Refuses to Require Parent Consent for Abortion (Bloomberg)
• COVID-19 mRNA Vaccine Labels Now Quantify Myocarditis Risk, But ACIP Wants Other Changes (Pink Sheet)
• Why 'emboldened' activist investors are taking the fight to biotechs (Fierce Pharma)